Council of Scientific and Industrial Research

Avinash Kumar

Ritu Trivedi

Naibedya Chattopadhyay

Prabhat Ranjan Mishra

Divya Singh

Jyoti Gautam

Vikram Khedgikar

Rakesh Maurya

Girish Kumar Jain

Anil Kumar Dwivedi

Rajender Singh Sangwan

Neelam Singh Sangwan

Srikanta Kumar Rath

Varsha Gupta

Sulekha Adhikary

Dharmendra Choudhary

Anirudha Karvande

Ashwni Verma

Girish Kumar Gupta

Priyanka Kushwaha

Shweta Sharma

Kamini Srivastava

Prabodh K Trivedi

Preety Dixit

Shelendra Pratap Singh

Wahajuddin

Sheelendra Pratap Singh

A method for prevention and/or treatment of diminution of bone tissue using a composition comprising a compound selected from Withaferin A (WFA), Withanolide A, and Withanone. The composition showed enhanced WFA bioavailability in rodents against plain WFA, promotes bone marrow cell differentiation, and increases the percent of bone volume to tissue volume (BV/TV %) by 3 folds as compared to free Withaferin A (WFA).

Pharmaceutical composition for the treatment of diminution of bone tissue

The present invention relates to bioactive fractions and compounds fromfor the prevention or treatment of osteo-health related disorders. The present invention relates in the field of pharmaceutical composition that provides new plant extracts, their fractions and pure compound isolated from natural sources that are useful for the prevention and/or treatment of various medical indications associated with estrogen dependent or independent diseases or syndromes or disorders preferably in the prevention or treatment of estrogen dependent or independent diseases or syndromes or disorders caused in humans and animals, and achievement of peak bone mass during skeletal growth and health in humans and animals. Particularly the present invention further relates to the processes for the preparation of biologically active extracts, fractions, and isolation of pure compounds, fromplant from the family Fabaceae their pharmaceutically acceptable salts and compositions of the principal aspect of the present invention.

[object Object]

The present invention relates to a microcapsule for controlled release of flavanoid compound and a process for preparation thereof. The microcapsule comprising a core particle consisting of a calcium salt, Pluronic F68 [poly (ethylene oxide-co-polypropylene oxide), block poly oxyethylene-polypropylene block copolymer], loaded with a flavanoid compound, the resulting core particle having a plurality of alternate layers of cationic and anionic polyelectrolytes adsorbed thereon and an outer layer formed by a bile salt, wherein the flavanoid is ranging between 10 to 96% by weight.

Controlled release micro-capsule for osteogenic action

Growing community of inventors

Lucknow, India

Avinash Kumar